{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:26:43Z","timestamp":1794565603221,"version":"4.9.1"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004488","name":"Croatian Science Foundation","doi-asserted-by":"publisher","award":["IP-2022-10-4658"],"award-info":[{"award-number":["IP-2022-10-4658"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P3-0449"],"award-info":[{"award-number":["P3-0449"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.118999","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:36:10Z","timestamp":1779838570000},"page":"118999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Update on inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type 1: Reports on structure-function relationship, docking and molecular dynamic simulations"],"prefix":"10.1016","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6015-0954","authenticated-orcid":false,"given":"Manuel","family":"Martinovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4392-3169","authenticated-orcid":false,"given":"Marketa","family":"Sedlacek Miskerikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-6677","authenticated-orcid":false,"given":"Jurica","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-4081","authenticated-orcid":false,"given":"Tea Lani\u0161nik","family":"Ri\u017ener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejmech.2026.118999_b1","first-page":"832","article-title":"17Beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production","volume":"24","author":"Aka","year":"2010","journal-title":"\"Mol. Endocrinol.\""},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.118999_b2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2005.11.035","article-title":"Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5","volume":"248","author":"Lin","year":"2006","journal-title":"\"Mol. Cell. Endocrinol.\""},{"issue":"3","key":"10.1016\/j.ejmech.2026.118999_b3","first-page":"281","article-title":"Molecular endocrinology of hydroxysteroid dehydrogenases","volume":"18","author":"Penning","year":"1997","journal-title":"\"Endocr. Rev.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0250001","article-title":"Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease","volume":"25","author":"Labrie","year":"2000","journal-title":"\"J. Mol. Endocrinol.\""},{"issue":"3","key":"10.1016\/j.ejmech.2026.118999_b5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/humupd\/dmg022","article-title":"Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action","volume":"9","author":"Penning","year":"2003","journal-title":"\"Hum. Reprod. Update\""},{"issue":"10","key":"10.1016\/j.ejmech.2026.118999_b6","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/S0021-9258(18)69746-7","article-title":"Human placental estradiol-17\u03b2 dehydrogenase","volume":"234","author":"Langer","year":"1959","journal-title":"\"J. Biol. Chem.\""},{"issue":"3","key":"10.1016\/j.ejmech.2026.118999_b7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0021-9258(18)64708-8","article-title":"Human placental estradiol-17\u03b2 dehydrogenase","volume":"233","author":"Langer","year":"1958","journal-title":"\"J. Biol. Chem.\""},{"issue":"5","key":"10.1016\/j.ejmech.2026.118999_b8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0969-2126(01)00183-6","article-title":"Structure of human estrogenic 17\u03b2-hydroxysteroid dehydrogenase at 2.20 \u00e5 resolution","volume":"3","author":"Ghosh","year":"1995","journal-title":"\"Structure\""},{"issue":"18","key":"10.1016\/j.ejmech.2026.118999_b9","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1021\/bi00018a001","article-title":"Short-chain dehydrogenases\/reductases (SDR)","volume":"34","author":"J\u00f6rnvall","year":"1995","journal-title":"\"Biochemistry\""},{"issue":"7","key":"10.1016\/j.ejmech.2026.118999_b10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0969-2126(00)00064-2","article-title":"The refined three-dimensional structure of 3\u03b1,20\u03b2-hydroxysteroid dehydrogenase and possible roles of the residues conserved in short-chain dehydrogenases","volume":"2","author":"Ghosh","year":"1994","journal-title":"\"Structure\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1074\/jbc.275.2.1105","article-title":"Dehydroepiandrosterone and dihydrotestosterone recognition by human estrogenic 17\u03b2-hydroxysteroid dehydrogenase","volume":"275","author":"Han","year":"2000","journal-title":"\"J. Biol. Chem.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b12","first-page":"54","article-title":"Current knowledge of the multifunctional 17\u03b2-hydroxysteroid dehydrogenase type 1 (HSD17B1)","volume":"588","author":"He","year":"2016","journal-title":"\"Gene\""},{"issue":"3","key":"10.1016\/j.ejmech.2026.118999_b13","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.96.3.840","article-title":"Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+","volume":"96","author":"Sawicki","year":"1999","journal-title":"\"Proc. Natl. Acad. Sci. U. S. A.\""},{"issue":"11","key":"10.1016\/j.ejmech.2026.118999_b14","first-page":"2155","article-title":"Crystal structures of human 17\u03b2-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP+ reveal the mechanism of substrate inhibition","volume":"286","author":"Li","year":"2019","journal-title":"\"FEBS J.\""},{"issue":"18","key":"10.1016\/j.ejmech.2026.118999_b15","doi-asserted-by":"crossref","first-page":"30552","DOI":"10.18632\/oncotarget.15547","article-title":"Estrogen and androgen-converting enzymes 17\u03b2-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17\u03b2-hydroxysteroid dehydrogenase type 1, 2, and breast cancer","volume":"8","author":"Hilborn","year":"2017","journal-title":"\"Oncotarget\""},{"key":"10.1016\/j.ejmech.2026.118999_b16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ebiom.2019.09.006","article-title":"Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry","volume":"48","author":"Yang","year":"2019","journal-title":"\"EBioMedicine\""},{"issue":"20","key":"10.1016\/j.ejmech.2026.118999_b17","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1158\/0008-5472.CAN-04-0446","article-title":"17Beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer","volume":"64","author":"Oduwole","year":"2004","journal-title":"\"Cancer Res.\""},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.118999_b18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0303-7207(00)00389-0","article-title":"Structure and function of 17\u03b2-hydroxysteroid dehydrogenase type 1 and type 2","volume":"171","author":"Vihko","year":"2001","journal-title":"\"Mol. Cell. Endocrinol.\""},{"key":"10.1016\/j.ejmech.2026.118999_b19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2021.03.019","article-title":"Pharmacological inhibition of 17\u03b2-hydroxysteroid dehydrogenase impairs human endometrial cancer growth in an orthotopic xenograft mouse model","volume":"508","author":"Xanthoulea","year":"2021","journal-title":"\"Cancer Lett.\""},{"issue":"106136","key":"10.1016\/j.ejmech.2026.118999_b20","article-title":"An irreversible inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type 1 inhibits estradiol synthesis in human endometriosis lesions and induces regression of the non-human primate endometriosis","volume":"222","author":"Poirier","year":"2022","journal-title":"\"J. Steroid Biochem. Mol. Biol.\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/pros.10139","article-title":"Differential expression of 17beta-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissues","volume":"53","author":"Koh","year":"2002","journal-title":"\"Prostate\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1479-5876-11-167","article-title":"Intratumoral localization and activity of 17\u03b2-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor","volume":"11","author":"Verma","year":"2013","journal-title":"\"J. Transl. Med.\""},{"issue":"2&3","key":"10.1016\/j.ejmech.2026.118999_b23","first-page":"120","article-title":"Identification of hydroxysteroid dehydrogenase type 1 as a potential bladder tumor marker","volume":"28","author":"Albadawy","year":"2024","journal-title":"\"Iran. Biomed. J.\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/092986708783330629","article-title":"Inhibitors of 17\u03b2-Hydroxysteroid dehydrogenase type 1","volume":"15","author":"Gobec","year":"2008","journal-title":"\"Curr. Med. Chem.\""},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2026.118999_b25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2005.12.007","article-title":"Structure and function of human 17beta-hydroxysteroid dehydrogenases","volume":"248","author":"Lukacik","year":"2006","journal-title":"\"Mol. Cell. Endocrinol.\""},{"key":"10.1016\/j.ejmech.2026.118999_b26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2018.10.001","article-title":"Inhibitors of 17\u03b2-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges","volume":"489","author":"Salah","year":"2019","journal-title":"\"Mol. Cell. Endocrinol.\""},{"issue":"109529","key":"10.1016\/j.ejmech.2026.118999_b27","article-title":"Recent advances in the development of 17beta-hydroxysteroid dehydrogenase inhibitors","volume":"213","author":"Poirier","year":"2025","journal-title":"\"Steroids\""},{"issue":"sup3","key":"10.1016\/j.ejmech.2026.118999_b28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/14756366.2016.1204610","article-title":"Comparative investigation of the in vitro inhibitory potencies of 13-epimeric estrones and D-secoestrones towards 17\u03b2-hydroxysteroid dehydrogenase type 1","volume":"31","author":"Herman","year":"2016","journal-title":"\"J. Enzym. Inhib. Med. Chem.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b29","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/14756366.2019.1634064","article-title":"Synthesis of substituted 15\u03b2-alkoxy estrone derivatives and their cofactor-dependent inhibitory effect on 17\u03b2-HSD1","volume":"34","author":"Herman","year":"2019","journal-title":"\"J. Enzym. Inhib. Med. Chem.\""},{"issue":"10","key":"10.1016\/j.ejmech.2026.118999_b30","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1535-7163.MCT-12-0299","article-title":"A new nonestrogenic steroidal inhibitor of 17\u03b2-hydroxysteroid dehydrogenase type I blocks the estrogen-dependent breast cancer tumor growth induced by estrone","volume":"11","author":"Ayan","year":"2012","journal-title":"\"Mol. Cancer Ther.\""},{"issue":"108856","key":"10.1016\/j.ejmech.2026.118999_b31","article-title":"Synthesis of 16\u03b2-derivatives of 3-(2-bromoethyl)-estra-1,3,5(10)-trien-17\u03b2-ol as inhibitors of 17\u03b2-HSD1 and\/or steroid sulfatase for the treatment of estrogen-dependent diseases","volume":"172","author":"Lesp\u00e9rance","year":"2021","journal-title":"\"Steroids\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/molecules28020632","article-title":"Chemical synthesis and biological evaluation of 3-substituted estrone\/estradiol derivatives as 17\u03b2-hydroxysteroid dehydrogenase type 1 inhibitors acting via a reverse orientation of the natural substrate estrone","volume":"28","author":"Ngueta","year":"2023","journal-title":"\"Molecules\""},{"issue":"17","key":"10.1016\/j.ejmech.2026.118999_b33","doi-asserted-by":"crossref","first-page":"11726","DOI":"10.1021\/acs.jmedchem.2c00589","article-title":"Dual targeting of steroid sulfatase and 17\u03b2-hydroxysteroid dehydrogenase type 1 by a novel drug-prodrug approach: A potential therapeutic option for the treatment of endometriosis","volume":"65","author":"Mohamed","year":"2022","journal-title":"\"J. Med. Chem.\""},{"issue":"12","key":"10.1016\/j.ejmech.2026.118999_b34","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1021\/acsmedchemlett.1c00462","article-title":"17\u03b2-Hydroxysteroid dehydrogenase type 1 inhibition: A potential treatment option for non-small cell lung cancer","volume":"12","author":"Gargano","year":"2021","journal-title":"\"ACS Med. Chem. Lett.\""},{"issue":"13","key":"10.1016\/j.ejmech.2026.118999_b35","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.1021\/acs.jmedchem.3c00571","article-title":"Potent dual inhibitors of steroid sulfatase and 17\u03b2-hydroxysteroid dehydrogenase type 1 with a suitable pharmacokinetic profile for in vivo proof-of-principle studies in an endometriosis mouse model","volume":"66","author":"Salah","year":"2023","journal-title":"\"J. Med. Chem.\""},{"key":"10.1016\/j.ejmech.2026.118999_b36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ejmech.2016.11.004","article-title":"Treatment of estrogen-dependent diseases: Design, synthesis and profiling of a selective 17\u03b2-HSD1 inhibitor with sub-nanomolar IC 50 for a proof-of-principle study","volume":"127","author":"Abdelsamie","year":"2017","journal-title":"\"Eur. J. Med. Chem.\""},{"key":"10.1016\/j.ejmech.2026.118999_b37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejmech.2019.05.084","article-title":"Development of potential preclinical candidates with promising in vitro ADME profile for the inhibition of type 1 and type 2 17\u03b2-Hydroxysteroid dehydrogenases: Design, synthesis, and biological evaluation","volume":"178","author":"Abdelsamie","year":"2019","journal-title":"\"Eur. J. Med. Chem.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/cmdc.202000762","article-title":"N-phenyl-1,2,3,4-tetrahydroisoquinoline: An alternative scaffold for the design of 17\u03b2-Hydroxysteroid dehydrogenase 1 inhibitors","volume":"16","author":"Mottinelli","year":"2021","journal-title":"\"ChemMedChem\""},{"issue":"114052","key":"10.1016\/j.ejmech.2026.118999_b39","article-title":"Bisphenol analogues inhibit human and rat 17\u03b2-hydroxysteroid dehydrogenase 1: 3D-quantitative structure-activity relationship (3D-QSAR) and in silico docking analysis","volume":"181","author":"Chen","year":"2023","journal-title":"\"Food Chem. Toxicol.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b40","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: Clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejmech.2026.118999_b42","series-title":"Drug Transporters","first-page":"285","article-title":"Importance of P-glycoprotein for drug\u2013drug interactions","author":"Glaeser","year":"2010"},{"key":"10.1016\/j.ejmech.2026.118999_b43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1412692","article-title":"A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions","volume":"15","author":"Bogaard","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jbiotec.2006.01.026","article-title":"Cytochromes P450 as versatile biocatalysts","volume":"124","author":"Bernhardt","year":"2006","journal-title":"J. Biotech."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118999_b45","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1021\/tx300192g","article-title":"Importance of multi-p450 inhibition in drug\u2013drug interactions: Evaluation of incidence, inhibition magnitude, and prediction from in vitro data","volume":"25","author":"Isoherranen","year":"2012","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118999_b47","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"\"Am. Fam. Phys.\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2014.12.001","article-title":"Beware of docking!","volume":"36","author":"Chen","year":"2015","journal-title":"\"Trends Pharmacol. Sci.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","article-title":"ProLIF: a library to encode molecular interactions as fingerprints","volume":"13","author":"Bouysset","year":"2021","journal-title":"\"J. Cheminform.\""},{"issue":"16","key":"10.1016\/j.ejmech.2026.118999_b50","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"\"J. Comput. Chem.\""},{"issue":"8","key":"10.1016\/j.ejmech.2026.118999_b51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0969-2126(96)00098-6","article-title":"The structure of a complex of human 17\u03b2-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors","volume":"4","author":"Breton","year":"1996","journal-title":"\"Structure\""},{"issue":"13","key":"10.1016\/j.ejmech.2026.118999_b52","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118999_b53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"\"J. Mol. Biol.\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"\"J. Comput. Chem.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b55","article-title":"Bringing the MMFF force field to the RDKit: implementation and validation","volume":"6","author":"Tosco","year":"2014","journal-title":"\"J. Cheminform.\""},{"key":"10.1016\/j.ejmech.2026.118999_b56","series-title":"Rdkit\/rdkit: 2024_09_6 (Q3 2024) release","author":"Landrum","year":"2025"},{"key":"10.1016\/j.ejmech.2026.118999_b57","series-title":"Meeko: molecule parameterization and software interoperability for docking and beyond","author":"Santos Martins","year":"2025"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118999_b58","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1073\/pnas.96.3.840","article-title":"Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+","volume":"96","author":"Sawicki","year":"1999","journal-title":"\"Proc. Natl. Acad. Sci. U. S. A.\""},{"issue":"9","key":"10.1016\/j.ejmech.2026.118999_b59","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"\"J. Comput. Chem.\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b60","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","article-title":"Automatic atom type and bond type perception in molecular mechanical calculations","volume":"25","author":"Wang","year":"2006","journal-title":"\"J. Mol. Graph. Model.\""},{"issue":"4","key":"10.1016\/j.ejmech.2026.118999_b61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jcc.540110404","article-title":"Atomic charges derived from semiempirical methods","volume":"11","author":"Besler","year":"1990","journal-title":"\"J. Comput. Chem.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b62","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"Ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"\"J. Chem. Theory Comput.\""},{"issue":"10","key":"10.1016\/j.ejmech.2026.118999_b63","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/protein\/12.10.851","article-title":"Redesign of the coenzyme specificity in l-lactate dehydrogenase from bacillus stearothermophilus using site-directed mutagenesis and media engineering","volume":"12","author":"Holmberg","year":"1999","journal-title":"\"Protein Eng. Des. Sel.\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b64","article-title":"Water models for biomolecular simulations","volume":"8","author":"Onufriev","year":"2018","journal-title":"\"Wiley Interdiscip. Rev. Comput. Mol. Sci.\""},{"issue":"3","key":"10.1016\/j.ejmech.2026.118999_b65","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/acs.jctc.9b00953","article-title":"Split the charge difference in two! a rule of thumb for adding proper amounts of ions in MD simulations","volume":"16","author":"Machado","year":"2020","journal-title":"\"J. Chem. Theory Comput.\""},{"issue":"2","key":"10.1016\/j.ejmech.2026.118999_b66","article-title":"Can resveratrol influence the activity of 11\u03b2-hydroxysteroid dehydrogenase type 1? A combined in silico and in vivo study","volume":"16","author":"Novak","year":"2023","journal-title":"\"Pharmaceuticals (Basel)\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b67","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0021-9991(83)90014-1","article-title":"Rattle: A \u201cvelocity\u201d version of the shake algorithm for molecular dynamics calculations","volume":"52","author":"Andersen","year":"1983","journal-title":"\"J. Comput. Phys.\""},{"issue":"12","key":"10.1016\/j.ejmech.2026.118999_b68","first-page":"10089","article-title":"Particle mesh ewald: An N\u22c5log(N) method for ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"\"J. Chem. Phys.\""},{"key":"10.1016\/j.ejmech.2026.118999_b69","series-title":"Amber 2022","author":"Case","year":"2022"},{"issue":"7","key":"10.1016\/j.ejmech.2026.118999_b70","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"\"J. Chem. Theory Comput.\""},{"issue":"1","key":"10.1016\/j.ejmech.2026.118999_b71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"<Scp>ucsf chimerax<\/scp>: Structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2020","journal-title":"Prot. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118999_b72","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"\"Expert Opin. Drug Discov.\""}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:55:48Z","timestamp":1794563748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":72,"alternative-id":["S0223523426004447"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118999","relation":{"is-supplemented-by":[{"id-type":"uri","id":"https:\/\/data.fulir.irb.hr\/data\/HSD17B1\/","asserted-by":"subject"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on inhibitors of 17-hydroxysteroid dehydrogenase type 1: Reports on structure-function relationship, docking and molecular dynamic simulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118999","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118999"}}